Remedium Lifecare Delivers Strong Q2 Results with Profit Nearly Doubling to INR 3862.34 Lakh

Mumbai, November 17,2025: Remedium Lifecare Limited announced its financial results for the quarter and half-year ended September 30, 2025. During the quarter ended September 30, 2025, the consolidated financial results reflect strong operational momentum. Consolidated revenue from operations stood at ₹11,105.82 lakh, with total income reaching ₹11,431.25 lakh. The quarter recorded a consolidated profit before […]

Continue Reading
Remedium

Remedium Lifecare: Ride the Pharma Wave with Our Rights Issue!

Mumbai (Maharashtra) [India], April 29: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, […]

Continue Reading

Remedium Lifecare Announces INR 49.19 Cr Rights Issue for Expansion

Mumbai (Maharashtra) [India], April 9: Remedium Lifecare Limited (BSE: 539561),a fast-growing manufacturer of pharmaceutical intermediates and specialty chemicals, is pleased to announce that it has received approval from the Bombay Stock Exchange (BSE) for its proposed rights issue. The approval paves the way for the company to raise growth capital from its existing shareholders, further […]

Continue Reading